BRIEF-China Medical System Entered Into Two Separate Exclusive Collaboration Agreements

Reuters
Sep 22
BRIEF-China Medical System Entered Into Two Separate Exclusive Collaboration Agreements

Sept 22 (Reuters) - China Medical System Holdings Ltd 0867.HK:

  • ENTERED INTO TWO SEPARATE EXCLUSIVE COLLABORATION AGREEMENTS WITH CHONGQING GENRIX BIOPHARMACEUTICAL

  • UNDER DEALS, OBTAINED EXCLUSIVE COMMERCIALIZATION RIGHTS FOR VECANTOXATUG AND SILEVIMIG INJECTIONS IN MAINLAND CHINA, OTHERS

Further company coverage: 0867.HK

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10